drugset / Trial / NCT04670653

Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis

NCT04670653

Phase 3 Withdrawn EMS
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Magnólia nasal gel in the treatment of moderate-severe persistent or moderate-severe intermittent allergic rhinitis.

Timeline

Start
2022-08-01
Primary completion
2023-07
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Subject MAGNÓLIA NASAL GEL Unknown Intranasal
Comparator Mometasone furoate Other / unclassified Intranasal

Indications